PDLIPDL BIOPHARMA, INC.

Nasdaq www.pdl.com


$ 2.48 $ -0.23 (-8.52 %)    

Wednesday, 30-Dec-2020 15:59:54 EST
QQQ $ 490.95 $ 4.06 (0.83 %)
DIA $ 392.84 $ -0.46 (-0.12 %)
SPY $ 551.46 $ 2.45 (0.45 %)
TLT $ 91.86 $ 1.19 (1.31 %)
GLD $ 217.99 $ 2.43 (1.13 %)
$ 2.47
$ 2.55 x 2,000
$ 2.60 x 100
-- - --
$ 2.09 - $ 3.86
30,270,721
na
286.29M
$ 1.02
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-29-2021 12-31-2020 10-K
2 11-13-2020 09-30-2020 10-Q
3 08-10-2020 06-30-2020 10-Q
4 05-11-2020 03-31-2020 10-Q
5 03-11-2020 12-31-2019 10-K
6 11-06-2019 09-30-2019 10-Q
7 08-07-2019 06-30-2019 10-Q
8 05-09-2019 03-31-2019 10-Q
9 03-15-2019 12-31-2018 10-K
10 11-07-2018 09-30-2018 10-Q
11 08-09-2018 06-30-2018 10-Q
12 05-09-2018 03-31-2018 10-Q
13 03-16-2018 12-31-2017 10-K
14 11-13-2017 09-30-2017 10-Q
15 08-03-2017 06-30-2017 10-Q
16 05-03-2017 03-31-2017 10-Q
17 03-01-2017 12-31-2016 10-K
18 11-03-2016 09-30-2016 10-Q
19 08-04-2016 06-30-2016 10-Q
20 05-04-2016 03-31-2016 10-Q
21 02-23-2016 12-31-2015 10-K
22 11-04-2015 09-30-2015 10-Q
23 08-05-2015 06-30-2015 10-Q
24 05-06-2015 03-31-2015 10-Q
25 02-23-2015 12-31-2014 10-K
26 11-10-2014 09-30-2014 10-Q
27 08-18-2014 06-30-2014 10-Q
28 05-12-2014 03-31-2014 10-Q
29 03-03-2014 12-31-2013 10-K
30 11-06-2013 09-30-2013 10-Q
31 08-08-2013 06-30-2013 10-Q
32 05-09-2013 03-31-2013 10-Q
33 03-01-2013 12-31-2012 10-K
34 11-05-2012 09-30-2012 10-Q
35 08-02-2012 06-30-2012 10-Q
36 05-03-2012 03-31-2012 10-Q
37 02-23-2012 12-31-2011 10-K
38 11-09-2011 09-30-2011 10-Q
39 07-29-2011 06-30-2011 10-Q
40 04-28-2011 03-31-2011 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Gainers AIkido Pharma (NASDAQ:AIKI) stock rose 8.13% to $0.93 during Wednesday's after-market session. At the close, AIkid...

 the-daily-biotech-pulse-osmotica-faces-second-fda-rejection-uk-conditionally-approves-astrazenecas-vaccine-candidate-hepion-nash-data

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...

 pdl-biopharma-reports-514m-capital-provision-deal-with-epps-investments-related-to-cos-previously-announced-settlement-deal-with-wellstat

PDL BioPharma, Inc. ("PDL" or the "Company") (NASDAQ:PDLI) announces it has entered into a Capital Provision Ag...

 pdl-biopharma-enters-514m-capital-provision-agreement-with-epps-investments-llc-regarding-pdls-previously-announced-settlement-agreement-with-wellstat

RENO, Nev., Dec. 14, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (NASDAQ:PDLI) announces ...

Core News & Articles

Gainers Panbela Therapeutics (NASDAQ:PBLA) shares moved upwards by 145.5% to $10.52 during Wednesday's after-market sessio...

Core News & Articles

PDL Announces Timeline for Voluntarily Delisting from Nasdaq INCLINE VILLAGE, Nev., Dec. 8, 2020 /PRNewswire/ -- PDL BioPharma...

 the-daily-biotech-pulse-astrazenecas-cancer-drug-flunks-covid-19-studies-five-prime-on-a-roll-morphosys-xencor-incyte-strike-cancer-deal

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...

Core News & Articles

Gainers

 recap-pdl-biopharma-q3-earnings
Recap: PDL BioPharma Q3 Earnings
11/11/2020 21:34:36

Shares of PDL BioPharma (NASDAQ:PDLI) rose 7.96% in after-market trading after the company reported Q3 results. Quarterly Resu...

 pdl-biopharma-q3-eps-004-misses-006-estimate-sales-412m-miss-550m-estimate

PDL BioPharma (NASDAQ:PDLI) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.06...

 the-daily-biotech-pulse-five-prime-skyrockets-multiple-conference-presentations-on-tap

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitti...

 earnings-scheduled-for-november-9-2020

  Companies Reporting Before The Bell • General Finance (NASDAQ:GFN) is projected to report quarterly earnings at $0.03 per s...

 the-week-ahead-in-biotech-earnings-conference-presentations-and-ipos

Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congr...

Core News & Articles

  Before 10 a.m. ET Tuesday, 14 stocks made new 52-week lows.

Core News & Articles

  On Monday morning, 17 companies achieved new lows for the year.

 58-biggest-movers-from-friday
58 Biggest Movers From Friday
10/05/2020 08:32:53

Gainers Xtant Medical Holdings, Inc. (NYSE: XTNT) shares climbed 91.4% to close at $1.57 on Friday after the company announc...